Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Genome-wide gene expression in a pharmacological hormonal transition model and its relation to depressive symptoms.

Mehta D, Rex-Haffner M, Søndergaard HB, Pinborg A, Binder EB, Frokjaer VG.

Acta Psychiatr Scand. 2019 Jul;140(1):77-84. doi: 10.1111/acps.13038. Epub 2019 May 24.

PMID:
31099405
2.

Evidence for oestrogen sensitivity in perinatal depression: pharmacological sex hormone manipulation study.

Mehta D, Rex-Haffner M, Søndergaard HB, Pinborg A, Binder EB, Frokjaer VG.

Br J Psychiatry. 2019 Sep;215(3):519-527. doi: 10.1192/bjp.2018.234.

PMID:
30457060
3.

Role of Serotonin Transporter Changes in Depressive Responses to Sex-Steroid Hormone Manipulation: A Positron Emission Tomography Study.

Frokjaer VG, Pinborg A, Holst KK, Overgaard A, Henningsson S, Heede M, Larsen EC, Jensen PS, Agn M, Nielsen AP, Stenbæk DS, da Cunha-Bang S, Lehel S, Siebner HR, Mikkelsen JD, Svarer C, Knudsen GM.

Biol Psychiatry. 2015 Oct 15;78(8):534-43. doi: 10.1016/j.biopsych.2015.04.015. Epub 2015 Apr 27.

PMID:
26004162
4.

Role of emotional processing in depressive responses to sex-hormone manipulation: a pharmacological fMRI study.

Henningsson S, Madsen KH, Pinborg A, Heede M, Knudsen GM, Siebner HR, Frokjaer VG.

Transl Psychiatry. 2015 Dec 1;5:e688. doi: 10.1038/tp.2015.184.

5.

Pharmacologically Induced Sex Hormone Fluctuation Effects on Resting-State Functional Connectivity in a Risk Model for Depression: A Randomized Trial.

Fisher PM, Larsen CB, Beliveau V, Henningsson S, Pinborg A, Holst KK, Jensen PS, Svarer C, Siebner HR, Knudsen GM, Frokjaer VG.

Neuropsychopharmacology. 2017 Jan;42(2):446-453. doi: 10.1038/npp.2016.208. Epub 2016 Sep 21.

6.

Sex hormone manipulation slows reaction time and increases labile mood in healthy women.

Stenbæk DS, Fisher PM, Budtz-Jørgensen E, Pinborg A, Hjordt LV, Jensen PS, Knudsen GM, Frokjaer VG.

Psychoneuroendocrinology. 2016 Jun;68:39-46. doi: 10.1016/j.psyneuen.2016.02.023. Epub 2016 Feb 26.

PMID:
26943343
7.

Neuroticism modulates mood responses to pharmacological sex hormone manipulation in healthy women.

Stenbæk DS, Budtz-Jørgensen E, Pinborg A, Jensen PS, Frokjaer VG.

Psychoneuroendocrinology. 2019 Jan;99:251-256. doi: 10.1016/j.psyneuen.2018.10.016. Epub 2018 Oct 26.

PMID:
30390443
8.

Sex-Steroid Hormone Manipulation Reduces Brain Response to Reward.

Macoveanu J, Henningsson S, Pinborg A, Jensen P, Knudsen GM, Frokjaer VG, Siebner HR.

Neuropsychopharmacology. 2016 Mar;41(4):1057-65. doi: 10.1038/npp.2015.236. Epub 2015 Aug 6.

9.

Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.

Albuquerque LE, Tso LO, Saconato H, Albuquerque MC, Macedo CR.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD002808. doi: 10.1002/14651858.CD002808.pub3. Review.

PMID:
23440788
10.

Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.

Siristatidis CS, Gibreel A, Basios G, Maheshwari A, Bhattacharya S.

Cochrane Database Syst Rev. 2015 Nov 9;(11):CD006919. doi: 10.1002/14651858.CD006919.pub4. Review.

PMID:
26558801
11.

Gonadotrophin-releasing hormone antagonists for assisted conception.

Al-Inany H, Aboulghar M.

Cochrane Database Syst Rev. 2001;(4):CD001750. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD001750.

PMID:
11687120
12.

Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling.

Mehta D, Newport DJ, Frishman G, Kraus L, Rex-Haffner M, Ritchie JC, Lori A, Knight BT, Stagnaro E, Ruepp A, Stowe ZN, Binder EB.

Psychol Med. 2014 Aug;44(11):2309-22. doi: 10.1017/S0033291713003231. Epub 2014 Feb 5.

PMID:
24495551
13.

Peri-pubertal gonadotropin-releasing hormone agonist treatment affects sex biased gene expression of amygdala in sheep.

Nuruddin S, Krogenæs A, Brynildsrud OB, Verhaegen S, Evans NP, Robinson JE, Haraldsen IR, Ropstad E.

Psychoneuroendocrinology. 2013 Dec;38(12):3115-27. doi: 10.1016/j.psyneuen.2013.09.011. Epub 2013 Sep 19.

PMID:
24103890
14.

Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.

Luo X, Ding L, Xu J, Williams RS, Chegini N.

Endocrinology. 2005 Mar;146(3):1074-96. Epub 2004 Dec 16.

PMID:
15604208
15.

Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.

Tan YH, Lethaby A.

Cochrane Database Syst Rev. 2013 Nov 15;(11):CD010241. doi: 10.1002/14651858.CD010241.pub2. Review.

PMID:
24234875
16.
17.

Sequential versus simultaneous use of chemotherapy and gonadotropin-releasing hormone agonist (GnRHa) among estrogen receptor (ER)-positive premenopausal breast cancer patients: effects on ovarian function, disease-free survival, and overall survival.

Zhang Y, Ji Y, Li J, Lei L, Wu S, Zuo W, Jia X, Wang Y, Mo M, Zhang N, Shen Z, Wu J, Shao Z, Liu G.

Breast Cancer Res Treat. 2018 Apr;168(3):679-686. doi: 10.1007/s10549-018-4660-y. Epub 2018 Jan 13.

PMID:
29332135
18.

Supplemental Content

Support Center